As of today (2024-04-28), the Trailing Annual Dividend Yield of ClearPoint Neuro is 0.00%.
The historical rank and industry rank for ClearPoint Neuro's Dividend Yield % or its related term are showing as below:
CLPT's Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.9 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
ClearPoint Neuro Dividend Yield % Historical Data
The historical data trend for ClearPoint Neuro's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ClearPoint Neuro's Dividend Yield %
For the Medical Devices subindustry, ClearPoint Neuro's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClearPoint Neuro's Dividend Yield % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where ClearPoint Neuro's Dividend Yield % falls into.
ClearPoint Neuro Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of ClearPoint Neuro's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
ClearPoint Neuro (ClearPoint Neuro) Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLPT has been successfully added to your 